Neurodevelopmental disorders encompass a heterogeneous group of conditions characterized by early-onset differences in cognition, behavior, and adaptive functioning. In parallel, the concept of neurodiversity has reframed these conditions as part of the natural spectrum of human neurocognitive variation, emphasizing diversity rather than pathology. In this context, the human microbiome has emerged as a key biological interface linking genetic predisposition, environmental exposures, immune regulation, and neurodevelopment. This chapter examines neurodevelopmental conditions through the lens of microbiome science, focusing on Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, Rett syndrome, Tourette syndrome, Down syndrome, and Prader–Willi syndrome. We summarize current evidence of gut and oral microbiome dysbiosis across these conditions and discuss mechanistic pathways involving the microbiota–gut–brain axis, including microbial metabolites, immune modulation, intestinal permeability, and neuroendocrine signaling. Furthermore, we review emerging therapeutic strategies aimed at modulating the microbiome—such as prebiotics, probiotics, synbiotics, dietary interventions, and fecal microbiota transplantation—highlighting their potential to improve gastrointestinal, metabolic, and neurobehavioral outcomes. Collectively, this chapter underscores the microbiome as a modifiable contributor to neurodevelopmental variability, offering insights into both vulnerability and resilience within the neurodivergent spectrum.

From Neurodevelopmental Alterations to Neurodiversity: The Microbiome Perspective / Elena Niccolai, Todorovic Nevena, Amedeo Amedei. - ELETTRONICO. - (2026), pp. 350-372. [10.1201/9781003635772-22]

From Neurodevelopmental Alterations to Neurodiversity: The Microbiome Perspective

Elena Niccolai;Amedeo Amedei
2026

Abstract

Neurodevelopmental disorders encompass a heterogeneous group of conditions characterized by early-onset differences in cognition, behavior, and adaptive functioning. In parallel, the concept of neurodiversity has reframed these conditions as part of the natural spectrum of human neurocognitive variation, emphasizing diversity rather than pathology. In this context, the human microbiome has emerged as a key biological interface linking genetic predisposition, environmental exposures, immune regulation, and neurodevelopment. This chapter examines neurodevelopmental conditions through the lens of microbiome science, focusing on Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, Rett syndrome, Tourette syndrome, Down syndrome, and Prader–Willi syndrome. We summarize current evidence of gut and oral microbiome dysbiosis across these conditions and discuss mechanistic pathways involving the microbiota–gut–brain axis, including microbial metabolites, immune modulation, intestinal permeability, and neuroendocrine signaling. Furthermore, we review emerging therapeutic strategies aimed at modulating the microbiome—such as prebiotics, probiotics, synbiotics, dietary interventions, and fecal microbiota transplantation—highlighting their potential to improve gastrointestinal, metabolic, and neurobehavioral outcomes. Collectively, this chapter underscores the microbiome as a modifiable contributor to neurodevelopmental variability, offering insights into both vulnerability and resilience within the neurodivergent spectrum.
2026
From Neurodevelopmental Alterations to Neurodiversity: The Microbiome Perspective
350
372
Elena Niccolai; Todorovic Nevena; Amedeo Amedei
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1499144
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact